EL Koldewijn
Papers
1
Total Citations
8
H-Index
1
About
Dr. E.L. Koldewijn is a distinguished urological surgeon whose research has significantly advanced the surgical management of bladder cancer, particularly through comparative effectiveness studies of robot-assisted versus open radical cystectomy. His most cited work, a 2021 nationwide Dutch study, provides critical intermediate-term survival data demonstrating that robot-assisted radical cystectomy (RARC) offers comparable oncological outcomes to open surgery for muscle-invasive and high-risk non-muscle invasive bladder cancer. This landmark analysis, drawing from comprehensive national registry data, has been cited 8 times and directly informs clinical decision-making by validating the oncological safety of minimally invasive approaches. Dr. Koldewijn’s contributions are pivotal in the ongoing debate about optimal surgical techniques, offering robust evidence that RARC can achieve equivalent survival while potentially reducing perioperative morbidity. His work exemplifies the integration of real-world evidence into urological oncology, guiding surgeons and patients toward evidence-based treatment choices. Through these impactful studies, Dr. Koldewijn has established himself as a key figure in the evolution of bladder cancer surgery, bridging technological innovation with rigorous outcomes research.
Research Focus
Key Achievements
Top Papers
- 1